NRIX and ROP Related Headlines

Go Back

Jun 8, 2026 01:00AM Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

NRIX and ROP Related Press Releases

Go Back

Jun 8, 2026 01:00AM Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

NRIX and ROP Related SEC Filings

Go Back